Condition: Tibial Fractures · Pain · Sponsor: Major Extremity Trauma Research Consortium
Two arm, pragmatic, randomized controlled multicenter Phase III noninferiority trial evaluating the efficacy of standard pain management without NSAIDs (Group 1) vs. standard pain management plus up to 6 weeks of NSAIDs (Group 2) in the treatment of tibial shaft fractures.
This description comes directly from the study's public registry record.
Thomas Higgins, MD · 801-870-113 · thomas.higgins@hsc.utah.edu
Katherine Frey, PhD · kparris1@jhu.edu
Always discuss trial participation with your own doctor first.
| Eskenazi Hospital | Indianapolis, Indiana, United States | Recruiting |
| Indiana University-Methodist | Indianapolis, Indiana, United States | Recruiting |
| University of Maryland R Adams Cowley Shock Trauma Center | Baltimore, Maryland, United States | Recruiting |
| Harvard Medical Center | Cambridge, Massachusetts, United States | Recruiting |
| Hennepin Health | Minneapolis, Minnesota, United States | Recruiting |
| University of Mississippi | Jackson, Mississippi, United States | Recruiting |
| The MetroHealth System | Cleveland, Ohio, United States | Recruiting |
| Allegheny General Hospital | Pittsburgh, Pennsylvania, United States | Recruiting |
| Vanderbilt Medical Center | Nashville, Tennessee, United States | Recruiting |
| University of Texas Health Science Center - Houston | Houston, Texas, United States | Recruiting |
| University of Utah | Salt Lake City, Utah, United States | Recruiting |
| Inova Fairfax Hospital | Falls Church, Virginia, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07006675